Sign in

CIK 0001610820

  • Non-accelerated filer
  • Smaller reporting company

BriaCell Therapeutics Corp.

Sign in to watch
Ticker
BCTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jul 31
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 604-921-1810
Business address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, British Columbia, Canada, V7T 2X1
Former names
Ansell Capital Corp.

Securities

  • BCTX Common Shares Nasdaq
  • BCTXL Warrants Nasdaq
  • BCTXZ Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-05-14 Lustig Marc Director Purchase +902,935 $2.22 $2.0M 2,542,935
2024-05-14 Lustig Marc Director Purchase · Common Stock Warrants +902,935 902,935
2022-12-28 Bondarenko Jamieson Chairman Purchase +28,000 $4.58 $128K 169,856
2022-12-23 Williams William V. President, CEO Purchase · Warrant +2,530 $1.94 $5K 29,802
2022-12-20 Bondarenko Jamieson Director Purchase +22,000 $5.35 $118K 141,856

Page 1 of 1 · 5 trades